Literature DB >> 1218297

Bone scan in chronic dialysis patients with evidence of secondary hyperparathyroidism and renal osteodystrophy.

W M Sy, A K Mittal.   

Abstract

Bone scans in 13 of 14 patients on chronic dialysis were found to be abnormal. Symmetrical increased activity was noted in the calvarium, mandible, sternum, shoulders, vertebrae, and the distal aspects of the femur and tibia, as well as the patella. The scan abnormality is felt to be most likely the result of secondary hyperparathyroidism because of clinical and laboratory data, and, in four, confirmatory tissue diagnoses. The scan findings support the data of some earlier investigations on bone isotopic accretion in hyperparathyroidism. However, co-existing osteomalacia giving rise to abnormal activity in some of the patients cannot be excluded. Dihydrotachysterol may have minimized the extent of osteomalacia in these patients. Osteoporosis was probably present in some patients, but it appears differently on scan. Osteosclerosis was not detected on radiographic examination. Scan manifestations, especially mandibular activity, were pronounced and appeared earlier than the radiographic changes. The degree and extent of abnormal activity correlated with the length of dialysis and the level of alkaline phosphatase.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1218297     DOI: 10.1259/0007-1285-48-575-878

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  15 in total

1.  Absent kidney sign associated with symmetrical and uniformly increased uptake of radiopharmaceutical by the skeleton.

Authors:  I Fogelman; J H McKillop; I T Boyle; W R Greig
Journal:  Eur J Nucl Med       Date:  1977-12-30

2.  Improvement of bone scintigraphy by quantitative evaluation compared with X-ray studies and iliac crest biopsy in malignant disease.

Authors:  J P Pfeifer; W Hill; U Büll; R Burkhardt; C M Kirsch
Journal:  Eur J Nucl Med       Date:  1983

3.  Abnormally high diffuse activity on bone scintigram. The importance of exposure time for its recognition.

Authors:  T Fukuda; Y Inoue; H Ochi; H Nakazima; H Sawa; Y Onoyama
Journal:  Eur J Nucl Med       Date:  1982

4.  Observations on computerized quantitative bone scintigraphy in renal osteodystrophy.

Authors:  P de Graaf; E K Pauwels; P H Vos; I M Schicht; J te Velde; J de Graeff
Journal:  Eur J Nucl Med       Date:  1984

5.  Kinetics of 99mtechnetium-tin-methylene-diphosphonate in normal subjects and pathological conditions: a simple index of bone metabolism.

Authors:  A Caniggia; A Vattimo
Journal:  Calcif Tissue Int       Date:  1980       Impact factor: 4.333

6.  Increased bone radiotracer uptake in renal osteodystrophy. Clinical evidence of hyperparathyroidism as the major cause.

Authors:  P de Graaf; J te Velde; E K Pauwels; I M Schicht; K Kleiverda; J de Graeff
Journal:  Eur J Nucl Med       Date:  1982

7.  Semi-quantitative interpretation of the bone scan in metabolic bone disease: definition and validation of the metabolic index.

Authors:  I Fogelman; D L Citrin; J G Turner; I D Hay; R G Bessent; I T Boyle
Journal:  Eur J Nucl Med       Date:  1979-08-01

8.  Diphosphonates in the evaluation of metabolic bone disease.

Authors:  I Fogelman; M L Smith
Journal:  Clin Rheumatol       Date:  1982-03       Impact factor: 2.980

Review 9.  Skeletal uptake of diphosphonate: a review.

Authors:  I Fogelman
Journal:  Eur J Nucl Med       Date:  1980-12

10.  Bone scintigraphy and densitometry in symptomatic haemodialysis bone disease.

Authors:  C Alberts; J B van der Schoot; E Busemann-Sokole
Journal:  Eur J Nucl Med       Date:  1981
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.